Functional Neuroimaging in Depression: Longitudinal Study of PET Metabolism in Correlation With Changes in Attentional Bias, Autobiographical Memory, Future Fluency and Facial Recognition in Depressed Patients Treated With Escitalopram.
Phase of Trial: Phase II
Latest Information Update: 12 Jun 2013
At a glance
- Drugs Escitalopram (Primary)
- Indications Major depressive disorder
- Focus Pharmacodynamics
- 30 Aug 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 30 Aug 2010 Actual end date (Oct 2009) added as reported by ClinicalTrials.gov.
- 28 Apr 2009 New trial record